International consensus on the use of tau PET imaging agent <sup>18</sup>F-flortaucipir in Alzheimer's disease.

Détails

Ressource 1Télécharger: 34978595_BIB_B769C584210D.pdf (1020.97 [Ko])
Etat: Public
Version: Final published version
Licence: CC BY 4.0
ID Serval
serval:BIB_B769C584210D
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
International consensus on the use of tau PET imaging agent <sup>18</sup>F-flortaucipir in Alzheimer's disease.
Périodique
European journal of nuclear medicine and molecular imaging
Auteur⸱e⸱s
Tian M., Civelek A.C., Carrio I., Watanabe Y., Kang K.W., Murakami K., Garibotto V., Prior J.O., Barthel H., Zhou R., Hou H., Dou X., Jin C., Zuo C., Zhang H.
Collaborateur⸱rice⸱s
Molecular Imaging-based Precision Medicine Task Group of A3 (China-Japan-Korea) Foresight Program
ISSN
1619-7089 (Electronic)
ISSN-L
1619-7070
Statut éditorial
Publié
Date de publication
02/2022
Peer-reviewed
Oui
Volume
49
Numéro
3
Pages
895-904
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: ppublish
Résumé
Positron emission tomography (PET) with the first and only tau targeting radiotracer of <sup>18</sup> F-flortaucipir approved by FDA has been increasingly used in depicting tau pathology deposition and distribution in patients with cognitive impairment. The goal of this international consensus is to help nuclear medicine practitioners procedurally perform <sup>18</sup> F-flortaucipir PET imaging.
A multidisciplinary task group formed by experts from various countries discussed and approved the consensus for <sup>18</sup> F-flortaucipir PET imaging in Alzheimer's disease (AD), focusing on clinical scenarios, patient preparation, and administered activities, as well as image acquisition, processing, interpretation, and reporting.
This international consensus and practice guideline will help to promote the standardized use of <sup>18</sup> F-flortaucipir PET in patients with AD. It will become an international standard for this purpose in clinical practice.
Mots-clé
Alzheimer Disease/diagnostic imaging, Alzheimer Disease/pathology, Carbolines, Cognitive Dysfunction/diagnostic imaging, Cognitive Dysfunction/pathology, Consensus, Humans, Positron-Emission Tomography/methods, Tomography, X-Ray Computed, tau Proteins, 18F-flortaucipir, Alzheimer’s disease (AD), Brain imaging, Positron emission tomography (PET)
Pubmed
Web of science
Open Access
Oui
Création de la notice
11/01/2022 13:50
Dernière modification de la notice
23/11/2022 7:14
Données d'usage